Related Experiment Video
Updated: Jul 14, 2026
08:33
Characterizing Histone Post-translational Modification Alterations in Yeast Neurodegenerative Proteinopathy Models
Published on: March 24, 2019
[Neurodegenerative amyloidoses: the yeast model]
Molekuliarnaia Biologiia
|May 23, 2007
Summary
Yeast prions, unlike human prions causing neurodegenerative diseases, are linked to inherited traits. Studying yeast prions offers insights into human amyloid diseases like Alzheimer's and Parkinson's.
Area of Science:
- Biochemistry
- Molecular Biology
- Neuroscience
Background:
- Over 20 human diseases, known as amyloidoses, are linked to protein misfolding and amyloid formation.
- Prion diseases are the only transmissible amyloid diseases, affecting humans and lower eukaryotes.
- While mammalian prions cause fatal neurodegenerative diseases, eukaryotic prions are associated with non-chromosomal inherited traits.
Purpose of the Study:
- To summarize studies on prions in the yeast Saccharomyces cerevisiae.
- To explore the utility of yeast as a model for investigating human amyloid diseases.
- To provide insights into prion diseases, Alzheimer's, Parkinson's, and Huntington's diseases.
Main Methods:
- Utilizing Saccharomyces cerevisiae as a model organism.
- Investigating prion formation and propagation in yeast.
- Comparative analysis of yeast and mammalian prions.
Main Results:
- Yeast prions exhibit distinct characteristics compared to mammalian prions.
- The yeast model successfully recapitulates aspects of amyloid formation relevant to human diseases.
- Studies highlight conserved mechanisms in prion biology across species.
Conclusions:
- Yeast serves as a valuable and tractable model for studying the fundamental mechanisms of prion diseases.
- Investigating yeast prions can illuminate pathways involved in human neurodegenerative amyloidoses.
- This research contributes to understanding the diverse roles and impacts of protein misfolding.
Related Concept Videos
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...